0001209191-22-002285.txt : 20220106 0001209191-22-002285.hdr.sgml : 20220106 20220106205704 ACCESSION NUMBER: 0001209191-22-002285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220104 FILED AS OF DATE: 20220106 DATE AS OF CHANGE: 20220106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHERMAN JEFFREY W CENTRAL INDEX KEY: 0001230482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 22516299 MAIL ADDRESS: STREET 1: C/O IDM PHARMA, INC. STREET 2: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-04 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001230482 SHERMAN JEFFREY W C/O HORIZON THERAPEUTICS PLC, 70 SAINT STEPHEN?S GREEN DUBLIN L2 D02 E2X4 IRELAND 0 1 0 0 EVP and Chief Medical Officer Ordinary Shares 2021-11-08 5 G 0 E 10729 0.00 D 9115 D Ordinary Shares 2021-11-08 5 G 0 E 10729 0.00 A 37808 I See footnote Ordinary Shares 2021-12-13 5 G 0 E 50 0.00 D 37758 I See footnote Ordinary Shares 2022-01-05 4 M 0 52570 A 61685 D Ordinary Shares 2022-01-05 4 A 0 32301 0.00 A 93986 D Ordinary Shares 2022-01-05 4 F 0 37675 0.00 D 56311 D Ordinary Shares 105808 I See footnote Ordinary Shares 66730 I By spouse Restricted Stock Units (RSU) 2022-01-04 4 A 0 19044 0.00 A Ordinary Shares 19044 19044 D Restricted Stock Units (RSU) 2022-01-05 4 M 0 12261 0.00 D Ordinary Shares 12261 0 D Restricted Stock Units (RSU) 2022-01-05 4 M 0 12095 0.00 D Ordinary Shares 12095 12095 D Restricted Stock Units (RSU) 2022-01-05 4 M 0 9222 0.00 D Ordinary Shares 9222 9223 D Restricted Stock Units (RSU) 2022-01-05 4 M 0 9678 0.00 D Ordinary Shares 9678 4834 D Restricted Stock Units (RSU) 2022-01-05 4 M 0 9314 0.00 D Ordinary Shares 9314 18628 D The shares are held in the Jeffrey W. Sherman Living Trust. Each RSU represents a contingent right to receive one ordinary share of the Issuer. On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2022, the PSUs vested as to the number of shares reported above. The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee. The RSU's vest 1/3rd annually on each anniversary of January 5, 2022. The RSU's vest 1/3rd annually on each anniversary of January 5, 2019. The RSU's vest 1/3rd annually on each anniversary of January 5, 2020. 50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023. Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023. The RSU's vest 1/3rd annually on each anniversary of January 5, 2021. /s/ Miles W. McHugh, Attorney-in-Fact 2022-01-06